In this wide-ranging fireside chat, Bio Protocol founder Paul Kohlhaas sits down with biotech and crypto investor Christian Angermayer, founder of the Apeiron Investment Group and early backer of atai Life Sciences, Cambrian Bio, and Rejuveron.
They explore the intersection of decentralized science (DeSci), longevity, psychedelics, AI, and personal freedom. Christian shares stories from building billion-dollar biotech ventures, discusses the failures of the traditional research system, and calls for radical honesty and autonomy in how we enhance the human experience.
From terminal patient trials to self-governed biohacking and regulatory overhauls, this is a bold blueprint for the future of health, medicine, and personal agency.